Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

NCT01555008 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Renal Impairment

Interventions

DRUG: LX4211
DRUG: LX4211 Placebo

Sponsor

Lexicon Pharmaceuticals